Hangzhou Tigermed Updates Final Dividend Details for 2024

Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ) has provided an announcement.

Hangzhou Tigermed Consulting Co., Ltd. announced an update to its final cash dividend for the year ended December 31, 2024. The dividend will be paid at a rate of HKD 3.245 per 10 shares, with an exchange rate of RMB 1 to HKD 1.0817. The ex-dividend date is set for June 12, 2025, and the payment date is July 31, 2025. The announcement includes details on withholding tax rates applicable to different types of shareholders, with non-resident enterprises and individuals facing a 10% tax rate, while mainland individual investors through the Southbound Trading Link will face a 20% tax rate. This update reflects the company’s commitment to shareholder returns and provides clarity on the financial implications for various stakeholders.

The most recent analyst rating on (HK:3347) stock is a Buy with a HK$38.00 price target. To see the full list of analyst forecasts on Hangzhou Tigermed Consulting Co., Ltd. Class H stock, see the HK:3347 Stock Forecast page.

More about Hangzhou Tigermed Consulting Co., Ltd. Class H

Hangzhou Tigermed Consulting Co., Ltd. is a company operating in the consulting industry, primarily offering services related to clinical research and development. The company focuses on providing comprehensive solutions for the pharmaceutical and biotechnology sectors, helping them navigate the complexities of clinical trials and regulatory requirements.

Average Trading Volume: 3,548,320

Technical Sentiment Signal: Sell

Current Market Cap: HK$38.84B

For detailed information about 3347 stock, go to TipRanks’ Stock Analysis page.